Addressing Low-Value Care and a Better Benefit Design at the V-BID Summit
As the country searches a new way to address cost of care, value-based insurance design (VBID), is gaining traction as one way of encouraging the use of high-value services and discouraging the use of low-value services.
As the country searches a new way to address cost of care, value-based insurance design (VBID), is gaining traction as one way of encouraging the use of high-value services and discouraging the use of low-value services. VBID would give patients access to treatments and services with high clinical value at reduced or no cost sharing. Currently, health plans tend to value all treatments and services as equal in clinical value to all patients, even though this is not the reality.
On March 14, the University of Michigan’s V-BID Center hosted its annual VBID Summit with discussions on aligning around value, how public payers are adopting VBID principles, addressing the use of low-value care services, and creating a smarter high-deductible health plan.
In this podcast, we speak with 3 speakers from the Summit. First up is Michelle Drozd of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, sat on a panel discussing smarter high-deductible health plans.
iTunes:
TuneIn:
Stitcher:
Listen above or through one of these podcast services:
Read coverage of the panels from the V-BID Summit:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Transforming Addiction Care: From Stigma to Support
September 16th 2025
- Navigating the Alzheimer Disease Blood Test Revolution
September 9th 2025
- AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025
- Managed Care Cast News Roundup: July 8, 2025
July 8th 2025